Democratic Republic of the Congo Dashboard

The country government, along with USAID and other donors, is compiling evidence on how TB affects the population, trends in disease prevention and control, progress against national strategies, and aggregated and disaggregated data for analysis and interpretation. Explore, analyze, and download tuberculosis (TB) data to inform efforts to maximize investments and move toward eliminating the disease.

How to use the charts: Roll over the data value to view the description. Click on and off of the key below each graph to make the values appear and disappear. Use the Icon for chart menumenu to print, download as an image, PDF, or CSV, or view the data table.

Other dashboards you may be interested in include the Summary Dashboard, DR-TB Dashboard, and COVID-19 Dashboard. To visualize additional TB data of your choosing, please see the Data Explorer.

REACH

TB Case Detection Rate or TB Treatment Coverage is one of the 10 core indicators of the PBMEF.

**This chart represents the available data as of Oct 27th, 2022.

Childhood TB Notifications is one of the 10 core indicators of the PBMEF.

Drug-Resistant TB Notifications is one of the 10 core indicators of the PBMEF.

Private Sector TB Notifications is one of the 10 core indicators of the PBMEF.

Bacteriological Diagnosis Coverage (Pulmonary TB) is one of the 10 core indicators of the PBMEF.

Contact Investigation Coverage is one of the 10 core indicators of the PBMEF.

CURE

TB Treatment Success Rate is one of the 10 core indicators of the PBMEF.

Drug-Resistant TB Treatment Success Rate is one of the 10 core indicators of the PBMEF.

PREVENT

SUSTAIN

Percent of TB Financing Expected from Domestic Sources is one of the 10 core indicators of the PBMEF.

Core Indicators

The Core Indicators of the PBMEF are critical to understanding progress in TB control; they provide standard comparisons across USAID's TB priority countries. Read more about the Core Indicators.

Indicator 2015 2016 2017 2018 2019 2020 2021 2022
TB Case Detection Rate or TB Treatment Coverage (DT-3) 46.75 49.66 55.38 60.62 61.99 67.89 70.30
NULL
Childhood TB Notifications (CH-5) 3,062 14,213 16,933 18,453
NULL
 22,340 26,773
NULL
Drug-Resistant TB Notifications (RN-1) 503 748 912 787 951 1,059 1,261
NULL
Private Sector TB Notifications (PR-1)
NULL
NULL
NULL
NULL
NULL
NULL
NULL
NULL
Bacteriological Diagnosis Coverage (Pulmonary TB) (DT-12) 82.77 81.04 79.50 77.17 76.71 76.58 74.06
NULL
Contact Investigation Coverage (CI-1)
NULL
NULL
NULL
NULL
 80.23 85.78 89.19
NULL
TB Treatment Success Rate (SS-1) 89.48 88.80 90.36 92.72 92.19 94.02
NULL
NULL
Drug-Resistant TB Treatment Success Rate (RS-1 86.78 85.12 81.54 83.89 77.44
NULL
NULL
NULL
Number of Individuals Started on TB Preventive Treatment (TPT) (PT-1)
NULL
NULL
NULL
 118,925 34,763 93,740 115,059
NULL
Percent of TB Financing Expected from Domestic Sources (SN-1)
NULL
NULL
NULL
 4.00 6.52 3.34 2.06 6.33

About the Data

The data used to generate the dashboards was obtained through the World Health Organization’s public website. The data includes the WHO TB burden estimates and data organized by countries, regions, and themes. These graphic representations are subject to change over time as data is updated.